Seikagaku Enters U.S. Distribution Agreement with Zimmer Biomet for VISCO-3
Seikagaku entered into an exclusive agreement with Zimmer Biomet for U.S. distribution of VISCO-3â„¢, a 3-injection hyaluronic acid-based viscosupplement for the treatment of knee osteoarthritis pain. Nov 08, 2016